| INTRODUCTION
Factitious disorders, also known as Münchausen syndrome and malingering are characterized by intentionally and surreptitiously inducing symptoms to portray physical and mental illness. [1] [2] [3] In cases of
Münchausen syndrome by proxy, a close person or relative of the patient (eg, the mother) induces the illness, which represents a form of child abuse. A representative case has been described by Schade et al, which ultimately resulted in the child's death. 4 Recently, "Münchausen by Internet" has been coined and describes affected individuals pretending to have an illness in a virtual environment, such as an online support group. 5 Attempts have been made to differentiate between factitious disorders and malingering, based on the premise that individuals with factitious disorders suffer from a mental illness and typically have no or few obvious signs of reward or benefit from producing the illness.
In contrast, malingering may be observed in patients who have a definite secondary gain associated with their symptoms. However, these delineations are ultimately artificial and ineffective. We chose the term factitious hypoglycemia in this report because it best describes the condition as "self-made" and "engineered" irrespective of an underlying psychiatric disorder and the potential for secondary gains.
There are several warning signs described in adults that raise suspicion of a factitious disorder. 1, 3, 6 These include difficult to explain symptoms which at times dramatically worsen or shift, change in symptoms following treatment, involvement of multiple medical providers and recurrent hospitalizations, and having a health care related occupation. Factitious hypoglycemia has been described in otherwise healthy adults and in patients with diabetes who are prescribed medications that can induce hypoglycemia even when taken appropriately. [7] [8] [9] We aimed to: (1) describe a case of factitious hypoglycemia in an adolescent female with type 1 diabetes focusing on the pitfalls of diagnosis, (2) systematically review the literature on factitious hypoglycemia in children and adolescents with diabetes, (3) determine whether patients share common characteristics, and (4) examine whether information on long-term outcome exists.
| CASE REPORT
A 15-year-old, multiracial, female patient with type 1 diabetes presented for evaluation of recurrent episodes of unexplained, severe hypoglycemia. Upon admission to the National Institutes of Health (NIH), she and her parent gave written informed assent and consent to enrollment in our natural history study of autoimmune diabetes and its complications (NCT 00896610). She had required 3 hospitalizations for hypoglycemia, the earliest occurring at the age 8 years. At that time, she had developed transient right-sided weakness, numbness, and difficulty reading. A head computer tomography and magnetic resonance imaging were normal, but an electroencephalogram was notable for focal slowing on the left side upon hypoventilation, consistent with hypoglycemia. The hypoglycemia episodes typically lasted between 1 and 3 days (maximally 2 weeks), and occurred every 3 to 6 months. Triggers for hypoglycemia were strenuous activity and excitement, but most episodes occurred with a 12 to 24-hour delay.
She also tended to become hypoglycemic a week after menstruation.
Endocrinologists at 2 other institutions had done extensive evaluations to rule out endocrine and gastrointestinal etiologies, but no pathology was found. During the last hospitalization, she had required 3 days of intravenous glucose infusions to maintain blood glucose concentrations above 60 mg/dL despite oral intake. Laboratory results showed plasma insulin concentrations of 483.0 μU/mL on admission with undetectable C-peptide. The patient denied excessive insulin dosing, instead reported appropriately discontinuing insulin administration once she noticed the onset of hypoglycemia. Upon discharge, the working diagnosis was hypoglycemia due to an autoimmune mechanism, potentially related to insulin binding antibodies.
Since the diagnosis of type 1 diabetes at the age 17 months, the patient had received insulin therapy. Initially she administered insulin via (MDI) and as of age 7 years, she used continuous subcutaneous insulin infusion (CSII or insulin pump). Most recently, she also used a continuous glucose monitoring device. Her blood glucose control had been suboptimal for at least 6 years with hemoglobin A1c (HbA1c) results in the 9% to 11% range (desirable <7%). Her total daily insulin dose was about 0.3 U/kg/d prior to this hospitalization. These low insulin doses were explained by fear of hypoglycemia. The patient's only other medication was an oral contraceptive for irregular periods.
She had not undergone any surgeries and her medical history was unremarkable except for type 1 diabetes. At the time of presentation, she was a sophomore in high school with excellent academic performance. She also participated in several athletic activities. During an overnight hospitalization, we confirmed that she tolerated expected doses of insulin (based on weight and pubertal status).
Results showed normal blood glucose concentrations during continuous infusion of glulisine Apidra™ (Sanofi) at 1 U/h. During exercise on a treadmill, the patient's blood glucose did not drop disproportionately. Thus, abnormally high insulin sensitivity or markedly high insulin-independent glucose uptake were excluded. Other differential diagnoses of hypoglycemia were also addressed; for example, adrenal insufficiency was ruled out. The patient was dismissed from the hospital and instructed to return when an episode of hypoglycemia occurred to evaluate appropriate counter-regulatory hormone responses. The topic of self-induced hypoglycemia was discussed, but vehemently rejected.
After a hiatus of several months without episodes of severe hypoglycemia, the patient returned due to a new episode. Blood glucose concentrations at home were between 20 and 40 mg/dL despite insulin pump suspension. The insulin pump dosing history was manually reviewed and reflected the patient's report. Her blood glucose had risen to 94 mg/dL with undetectable insulin and C-peptide concentrations. Anti-insulin antibodies were 0.48 nmol/L, cortisol: 13.6 mcg/dL, and growth hormone: 17.9 ng/mL. The patient returned 5 days later after another episode. Insulin and C-peptide were again undetectable. Glucagon was 13 pg/mL, and a drug screen for hypoglycemic agents was negative.
The department of laboratory medicine was contacted to obtain information about the insulin immunoassay used at our institution.
The samples had been assayed with a Roche Cobas 6000 analyzer (Roche Diagnostics USA) (normal fasting range: 2.6-24.9 mcIU/mL [19-178 pmol/L]; inter-assay CV: 2.5%-6.0%; intra-assay CV: 1.0%-1.2%). It was realized that this assay, while extremely sensitive to endogenous insulin, had highly variable cross-reactivity with several insulin analogs. In particular, this assay had no cross-reactivity with insulin glulisine. [10] [11] [12] [13] [14] Thus, stored plasma samples were sent out to be analyzed with an Abbott Architect immunoassay. This time, the insulin concentration was reported as 26 μU/mL. Considering that the Abbott Architect has approximately 10% cross-reactivity with glulisine, the circulating insulin concentration was estimated in the 200 to 300 μU/mL range.
In the weeks to follow, the patient visited one of her other endocrinologists. Upon review of her insulin pump's memory, it was found that she had been priming her insulin pump with large amounts of insulin that corresponded with the dates of her most recent hypoglycemic episodes. Thus, the episodes had been induced by infusing instead of discarding insulin to fill the catheter connecting the insulin pump with the insertion site. Up to 327 units of insulin had been recorded to be used for "priming." When presented with this information, the patient suggested that these doses had been administered unintentionally, but later admitted that she had self-induced hypoglycemia via a variety of strategies (ie, priming or self-injecting insulin)
without her caregiver's knowledge for approximately 7 years, including the first episode which occurred at 8 years of age.
Following the diagnosis of factitious hypoglycemia, the patient's care was consolidated (she had been followed by 8 physicians and used 2 different insulin pumps). It was decided that she would receive care from 1 primary care provider and 1 pediatric endocrinologist, and use 1 insulin pump. Individual and family psychotherapy was recommended. Six months later, no further self-induced hypoglycemia occurred. The family decided to only pursue individual psychotherapy. The patient continued to do well academically, but was diagnosed with depression. Hearing loss, which had previously been described as mild, started to interfere with daily life, and hearing aids were recommended.
| METHODS
We performed a systematic review of the English literature through 
| RESULTS
We identified a total of 83 articles of which 14 met the inclusion criteria (Table 1) . These reports described 39 cases. We analyzed patient characteristics including our own patient presented in this report. Of 40 cases, the majority was female (63%). Average age was 13.5 AE 2.0 years (range: 9.5-18.0) and average diabetes duration was almost 6 years. All but 1 report, which described a 10. [n = 1]) were among the most frequently cited. In 6 cases, the wish for more food, specifically sweets, was described. Other explanations included school avoidance, attention seeking, disease denial, wish to reduce parental anxiety about diabetes-related complications, coverup for omitted insulin injections, induction of excitement, and selfpunishment. In all reports with a documented method of hypoglycemia induction, insulin was used. In most cases (70%) counseling or psychiatric treatment were mentioned as intervention after the diagnosis of factitious hypoglycemia had been made (with no information on intervention or follow-up in 9 cases). Two cases specifically mentioned suicide attempts in the follow-up period and 1 described switching from factitious hypoglycemia to a new symptom (selfstrangulation for excitement). developed other coping mechanisms which explain this change in behavior.
| DISCUSSION

| Definitions and nomenclature
The terms to describe factitious disorders are confusing since "factitious" (which derives from the Latin verb facere and means to do or to make) has been used in the context of willfully induced illnesses and haphazardly experienced conditions. An example of the latter is factitious Graves' disease due to biotin immunoassay interference described in an asymptomatic patient with abnormal laboratory results. 35 This patient did not pretend to have an illness, but merely took a medication which caused laboratory results mimicking hyperthyroidism. In the present review, we define factitious as intentionally 
| Prevalence
In adults, the 1-year prevalence of factitious disorders has been estimated at 1.3% based on a survey of physicians in private practice and hospital consultants, 36 however, it may be markedly higher in specialty clinics for patients with diagnostically challenging problems.
Compared to other subspecialties, endocrinology is a field in which factitious disorders are disproportionality often reported. 3 In addition to factitious hypoglycemia, presentations include Cushing's syndrome, 37 thyrotoxicosis, and endocrine neoplasias. Pediatric factitious disorders have been estimated to occur at a similar prevalence compared to adults (0.7%-1.8%) but the prevalence of factitious hypoglycemia in children and adolescents with diabetes is completely unknown. 38, 39 We identified only 40 cases in this review (including our own), but the frequency is likely under-reported because most pediatric endocrinologists can recall one or more cases in their practice. A structured interview of 241 Austrian children and adolescents with type 1 diabetes revealed that 55 (23%) admitted to intentional insulin overdosing. However, the study was conducted to assess the prevalence of under-and over-dosing, and not to examine selfinduced, surreptitious hypoglycemia.
| Diagnostic challenges
It is worth noting that in many factitious disorders, symptoms are often inconsistent and difficult to explain. However, factitious hypoglycemia in patients with diabetes mimics a side effect of the prescribed treatment. Thus, diagnosing this disorder is even more difficult. The typical laboratory paradigm to differentiate exogenous insulin induced factitious hypoglycemia (low C-peptide, high insulin)
from an insulinoma (high C-peptide, high insulin) or other causes (low C-peptide, low insulin) 40 may not be easily applicable. Today's highly Abbreviations: DIDMOAD, diabetes insipidus, diabetes mellitus, optic atrophy, and deafness; DKA, diabetic ketoacidosis; HbA1c, hemoglobin A1c; MDI, multiple daily injections; NPH, neutral protamine Hagedorn;
T1DM, type 1 diabetes mellitus.
specific insulin assays do not (or to a lower degree) detect recombinant insulin analogs. [10] [11] [12] [13] [14] An additional diagnostic challenge is the preconceived notion that children do not intentionally harm themselves. However, it is known that the ultimate self-harm, suicide, occurs in children and adolescents. 41 Another factor may be the preference of the involved physicians, especially at academic centers, to rather pursue an intellectually challenging diagnosis than to face the unsettling prospect of factitious hypoglycemia. This is particularly the case, when the treating physician and health care professionals have a long-standing and caring relationship with the patient. Thus, the correct and timely diagnosis requires a high level of suspicion, a very careful review of the administered insulin doses comparing expected insulin use with actual use, download of insulin pump information or review of insulin/blood glucose logs, and a blood sample obtained during hypoglycemia to simultaneously determine plasma glucose, Cpeptide and insulin (measured with an assay that picks up exogenous insulin).
| Reasons for self-inducing hypoglycemia
The most obvious and frequently mentioned reason is the wish to eat more, especially sweets. Depression, a cry for help and attention, and school avoidance are other common factors. One early case report describes a patient's intense enjoyment about her parents' distress and physicians' helplessness. 15 This 14-year-old girl expressed a wish for revenge because she alone had type 1 diabetes in her family, while all the others were healthy. Some children try to avoid hyperglycemia at all cost causing frequent hypoglycemia in response to their parents' fear of long-term diabetic complications. 29 Other adolescents were described who had let their diabetes control slip, had not injected insulin for a while and then overcompensated. 29 One 15-year-old boy described the rapid onset of hypoglycemia as exciting and associated with euphoria. 27 In adults, these exhilarating feelings have also been reported when insulin is administered together with illicit drugs and alcohol. 42 Depression appears to be an important contributing factor. In youth with type 1 diabetes, its prevalence has been found as high as 1 in 7 youths, which is at least twice as high as in youths in general. 43 Several cases of attempted or completed suicide with insulin overdoses have been reported in adolescents in whom no clear history of preceding factious hypoglycemia was known. 20, 21, [44] [45] [46] One can only speculate that previous hypoglycemic episodes were also intentionally self-induced and might have been a warning sign. A recent analysis documented excess all-cause mortality in young individuals (less than 30 years of age) with type 1 diabetes and found that the most common causes were ketoacidosis, likely hypoglycemia and suicide. 47 Though no details about the individual cases are available, it is possible that some of the hypoglycemia episodes were induced intentionally and some of the suicides were committed with insulin overdoses.
| Typical characteristics
Our results show that a high percentage of youths with factitious hypoglycemia suffer from depression and suicidality compared to the overall percentage of children and adolescents (US population) with or without type 1 diabetes. 44, 48 Other common features are being in puberty, having long-standing type 1 diabetes with poor blood glucose control and using disproportionately low insulin doses. Difficult family and psychosocial environments were frequently reported spanning across a wide range of socioeconomic levels. Surprisingly, several case reports mentioned that the affected youths performed well in school, as was the case in our patient. We did not identify cases which occurred due to ingestion of oral hypoglycemic agents; instead all youths used insulin to induce hypoglycemia. Despite type 2 diabetes representing a considerable proportion of pediatric diabetes, no cases of factitious hypoglycemia were found in the literature.
| Effect on patient-parent-physician relationship
Patients who surreptitiously inflict self-harm disrupt the intimate, 
| Follow-up and long-term outcome
Follow-up information on patients with diabetes and factitious hypoglycemia is sparse. Case reports describe varying outcomes in adults ranging from resolution of hypoglycemia, to a shift towards other factitious symptoms and suicide. 7 Similar to adults, systematic follow-up of children suffering from factitious hypoglycemia does not exist. This is inherent in the diagnosis because patients often avoid continued care provided by physicians and health professionals who made the diagnosis and thus "exposed" them. However, 2 cases are described in which referral to counseling and treatment by child psychiatry prevented further episodes for 1.5 and 4.5 years, respectively. 25, 27 Another factor preventing long-term follow-up is the necessary transition from pediatric to adult endocrine care, during which information on the detailed history of the patient may get lost. The importance of follow-up is also highlighted by the fact that some cases of Münchausen by proxy are inflicted by parents who themselves displayed factitious disorders in adolescence. 49 Furthermore, it has been estimated that many cases of factitious disorders occurring in young adults started in adolescence. 50 
| CONCLUSIONS
The herein described case has typical characteristics of a factitious disorder, which is especially evident in hindsight. These include difficult to explain timing of hypoglycemia (ie, long after exercise), unexplained waxing and waning of severe hypoglycemia episodes, use of 2 insulin pumps and involvement of multiple medical providers.
Even when laboratory results supported the diagnosis of surreptitious insulin administration during her last emergency room visit and hospitalization, another differential diagnosis was given priority (interference by insulin antibodies). This likely occurred due to the longstanding, close and caring patient-physician relationship. Acknowledgement of the factitious nature of the symptoms by both, physicians and parent, would have meant acknowledgement of betrayal.
The diagnosis was further delayed during the subsequent work-up because of the use of an insulin assay that did not detect exogenous insulin. Similar cases have previously been reported. [10] [11] [12] [13] [14] Many inventive strategies have been described for surreptitious insulin administration. Our patient is not the first to have used the priming function of her insulin pump. 30, 32 Only through careful review of the "priming" or "cannula fill" history was this technique discovered, while the review of daily insulin dosing does not include the amount used for priming.
Further common features of our patient and others described in Finally, we highlight a lack of knowledge on effective treatments and long-term outcome. Information on treatment and outcome for these patients is of vital importance, as the discovery and diagnosis of factitious hypoglycemia can often be dramatic and distressing.
Additionally, because factitious hypoglycemia is a life-threatening behavior, it is imperative to be addressed in a timely manner to prevent catastrophic outcomes such as permanent brain damage or death.
